Ketogenic Diets and Epilepsy: New Insights into Brain Protection
A new review published in The Lancet Neurology offers the latest scientific explanations for why ketogenic diets effectively reduce seizures in people with epilepsy, and suggests potential benefits beyond seizure control. Researchers from the University of Colorado Anschutz Medical Campus and UT Southwestern Medical Center collaborated on the study, synthesizing research from the past five years to clarify the mechanisms behind this therapeutic approach.
How Ketogenic Diets Impact the Brain
For years, clinicians have observed the positive effects of ketogenic diets on patients with drug-resistant epilepsy. This review details how these high-fat, low-carbohydrate diets strengthen the brain’s energy systems, reduce inflammation, and protect neurons – benefits that often surpass those provided by conventional medications.
The diets work by shifting the brain’s primary fuel source from glucose to ketones. When carbohydrate intake is significantly limited, the body begins to break down fats, producing ketones. These ketones provide a more stable and efficient energy source for the brain, helping to stabilize overactive neurons and regulate energy levels. This stabilization can reduce the likelihood of seizures.
Expanding Understanding and Addressing Research Gaps
Anna Figueroa, PharmD, the study’s first author and a researcher at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz, explains that the review aims to provide a comprehensive understanding of how these diets function, identify areas where further research is needed, and explore strategies for implementing ketogenic diets more effectively. “By bringing together the latest clinical evidence and basic science research, we aim to provide an integrated understanding on how these diets work, identify gaps in current knowledge and highlight opportunities for diet implementation strategies,” Figueroa stated.
The authors also hope these insights will spur the development of new drugs that mimic the therapeutic effects of the ketogenic diet, potentially offering a more sustainable treatment option for patients.
The Need for More Adult-Focused Research
Currently, much of the research on ketogenic diets for epilepsy focuses on children. While some pediatric studies have compared different ketogenic diet variations and evaluated them against standard epilepsy care, these studies remain limited. The evidence gap is even wider in adults, with very few randomized controlled trials conducted in adult populations – only one in the past five years.
The review highlights that adults may experience changes in their ability to break down fat over time, potentially due to long-term use of antiseizure medications, which can affect their tolerance and response to ketogenic diets. This suggests that initiating the diet earlier in life, particularly during childhood, may yield the most significant benefits.
Potential Beyond Epilepsy
While the review primarily focuses on epilepsy, the underlying mechanisms suggest that ketogenic diet approaches could be beneficial for other neurological conditions. Emerging evidence indicates potential therapeutic value for a range of disorders, suggesting that metabolism-based therapies may have broader applications.
Future Directions
The findings underscore the need for earlier adoption of ketogenic diets, alongside larger-scale randomized controlled trials to assess long-term effects. Continued innovation in both the implementation of the diet and the development of diet-mimicking therapies is crucial to improve patient outcomes, and sustainability.
Source: University of Colorado Anschutz Medical Campus
Related reading